The metformin hydrochloride tablets market was valued at USD 10.54 Billion in 2025 and is expected to grow at a CAGR of 6.30%, reaching USD 19.42 Billion by 2035. The growth is driven by rising prevalence of type 2 diabetes and preference for cost-effective oral anti-diabetic therapies.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
6.3%
Value in USD Billion
2026-2035
*this image is indicative*
Metformin hydrochloride tablets are a type of medication which is used to treat diabetes mellitus by reducing the level of glucose released into the patient’s bloodstream, while enhancing utilisation of glucose already present in the patient. Classified as an antidiabetic agent, the active ingredient in the tablets is metformin. This medicine also helps improve response to insulin, reducing the risk of complications from unmanaged diabetes.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR’s report titled “Metformin Hydrochloride Tablets Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Distribution Channel
Market Breakup by Region
The metformin hydrochloride-extended release segment, based on type, accounts for a healthy share of the metformin hydrochloride tablets market. Metformin hydrochloride- extended release tablets increase gastrointestinal tolerability and patient adherence, enabling one daily dosage, and are available in various branded and generic formulations. Moreover, this type of medication is beneficial for patients with diabetes mellitus who require better glycaemic control and enhanced management of comorbidity conditions. The increasing demand for Glucophage, which is a popular type of extended release MF, is further adding to the segment’s growth. Over the forecast period, the anticipated increase in transition from immediate to extended metformin hydrochloride, owing to the rising awareness about the product, is further providing impetus to the global metformin hydrochloride tablets market.
Based on distribution channel, the retail pharmacies segment accounts for a significant share in the metformin hydrochloride tablets market. This can be attributed to the easy accessibility of drugs and medicines from these stores which are established across rural, semi-urban, and urban areas of the emerging economies as well as developed nations. In addition, retail pharmacies are suited for patients who require long-term treatment and supply of metformin hydrochloride tablets on a regular basis. Competitive pricing and availability of a wide range of medications for patients with comorbidities are available in retail pharmacies.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global metformin hydrochloride tablets market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.
Bristol-Myers Squibb Company is a leading pharmaceutical company which develops and delivers innovative medicines to treat severe chronic conditions. The company is dedicated towards improving the cancer treatment infrastructure with its advanced medical solutions. Bristol-Myers Squibb Company was established in 1887 and is currently headquartered in New York, United States.
Glenmark Pharmaceuticals Ltd is a prominent pharmaceutical company which has provided innovative and ground breaking medical solutions, such as Candid cream, across the world. The company is dedicated towards producing and marketing generic and branded pharmaceutical solutions. Glenmark Pharmaceuticals was founded in 1977 and is currently headquartered in Maharashtra, India.
Teva Pharmaceutical Industries Ltd. is a leading generic medicine manufacturer which develops high-quality biopharmaceutical treatment products in order to combat chronic diseases and infections. The company was founded in 1944 and is currently headquartered in Tel Aviv, Israel. Apart from manufacturing generic drugs, Teva Pharmaceutical Industries also offers active pharmaceutical ingredients.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other market players include Lupin Inc, Shandong Keyuan Pharmaceutical Co., Ltd., Merck and Co.,Inc., and Vistin Pharma ASA, among others.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is estimated to grow at a CAGR of 6.30% between 2026 and 2035.
The market is estimated to witness a healthy growth in the forecast period of 2026-2035 to reach a value of USD 19.42 Billion by 2035.
The increasing prevalence of diabetes mellitus among the adult population, growing prevalence of cancer, and increasing preference for tablets over injections are the major drivers of the market.
The key trends in the market include the growing research and development activities, potential uses of metformin hydrochloride tablets in the treatment of cancer, and expanding network of retail pharmacies.
Metformin hydrochloride tablet is used for reducing the glucose levels in the body in order to treat diabetes mellitus.
Metformin hydrochloride tablets can cause loss of appetite which can help obese patients lose weight.
Metformin hydrochloride-immediate release and metformin hydrochloride-extended release are the different types of metformin hydrochloride tablets in the market.
Hospital pharmacies, and retail pharmacies, among others, are the primary distribution channels for metformin hydrochloride tablets in the market.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the major regions included in the market report.
Bristol-Myers Squibb Company, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Lupin Inc, Shandong Keyuan Pharmaceutical Co., Ltd., Merck and Co.,Inc., and Vistin Pharma ASA, among others, are the key players of the global metformin hydrochloride tablets market, according to the report.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share